.png)
Watch our on-demand program recording where globally recognized experts share actionable insights on leveraging the latest technology with AI to streamline Candidate Identification and overcome long-standing clinical trial recruitment challenges.
Dr. Eichenbaum is a retina specialist, Partner and Director of Research at RVAF and Collaborative Associate Professor at the Morsani College of Medicine at the University of South Florida, with a distinguished career in the diagnosis and treatment of vitreoretinal diseases. He completed his ophthalmology residency at the University of South Florida, and a surgical retina fellowship at Tufts New England Eye Center and Ophthalmic Consultants of Boston. He has served as Principal Investigator in over 100 retina clinical trials and has published in several professional journals and textbook chapters.
Dr. Khanani is Managing Partner, Director of Clinical Research, and Director of Fellowship at Sierra Eye Associates, and Clinical Professor at the University of Nevada, Reno. He has led more than 120 clinical trials, including serving as chair of the Phase 3 GATHER2 steering committee that supported IZERVAY’s approval for geographic atrophy. Widely published with over 150 scientific papers, Dr. Khanani is a frequent international speaker, founder of the Clinical Trials at the Summit meeting, and an active member of leading retinal societies. His contributions to advancing treatments for retinal diseases have earned him numerous honors, including the ASRS Presidents’ Young Investigator Award and the ASRS Presidential Award.
Dr. Omer Trivizki, MD, MBA, is a renowned retina specialist at Tel Aviv Medical Center, serving as Vice Chair of Ophthalmology and leads the Digital Initiative. He also holds a Clinical Senior Lecturer position at Tel Aviv University and is a Research Associate at the Bascom Palmer Eye Institute. He is dedicated to advancing the integration of AI, focusing on developing innovative imaging-based analysis workflows to improve efficiency of trials and patient recruitment in retinal studies.